MedTrace Logo

Mindfulness Meditation: Alleviating Symptoms and Inflammation in Nurses

NCT06635278 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-10-10

No results posted yet for this study

Summary

Background: Nurses have experienced several stressors, the most important of which are increased workloads, long shifts, patients' negative results, some patients not responding to treatment, death at high rates, late detection of disease cases, lack of social support system, and limited typical coping.

Aim: The purpose of this study is to assess the effectiveness of mindfulness meditation for clinical nurses to improve perceived stress and somatic symptoms and pro-inflammatory factors. Among Jordanian clinical nurses.

Methodology: The study will be conducted using a post-test randomized controlled experimental design. The study data will be collected using a self-report questionnaire and blood sampling from 102 nurses in in King Abdullah hospitals at baseline and at the end of intervention. Data were analyzed using the Statistical Package for Social Science (SPSS), Version 26.

Conditions

Interventions

BEHAVIORAL

Mindfulness meditation

The experimental group received eight 60-minute weekly sessions of mindfulness meditation over eight weeks in a private and quiet room at the hospital, according to Smith's (2005) recommendation. The study intervention was an audio based MBI sent to them by the WhatsApp application. It is a free, self-paced program developed by a study researcher based on the Smith's (2005) protocol. The theory-based program (Smith, 2005) includes the ABC standardized versions of MBI (Smith, 2005), described as follows: * Meditation of the body (Body sense meditation) * Meditation of the body (Rocking meditation) * Meditation of the body (Breathing meditation) * Meditation of mind (Mentra meditation) * Meditation of mind (visual Image) * Meditation of sense (External image) * Meditation of the senses (A sound) * Open monitoring (Mindfulness)

Sponsors & Collaborators

  • Jordan University of Science and Technology

    lead OTHER

Principal Investigators

  • Hossam Alhawatmeh, Doctoral degree · Jordan University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-10-01
Completion
2024-10-10

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06635278 on ClinicalTrials.gov